NCT01116778View on ClinicalTrials.gov

the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis

PHASE3CompletedINTERVENTIONAL
Enrollment

236

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

January 31, 2012

Study Completion Date

June 30, 2012

Conditions
Perennial Allergic RhinitisProbioticsLactobacillus Paracasei GMNL-32 (eN-Lac®)
Interventions
BIOLOGICAL

eN-Lac®

One capsule with 2x10\^9 colony forming unit (cfu) LP GMNL-32, once daily, po

OTHER

Placebo

One placebo capsule, once daily, po

Trial Locations (4)

105

Chang Gung Children's Hospital, Taipei

231

Cardinal Tien Hospital, Xindian

10341

Taipei City Hospital Renai Branch, Taipei

10449

MacKay Memorial Hospital, Taipei

Sponsors
All Listed Sponsors
collaborator

Biomedical Development Corporation

INDUSTRY

lead

GenMont Biotech Incorporation

INDUSTRY